國立虎尾科技大學 |

Treating Urothelial Bladder Cancer

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Treating Urothelial Bladder Cancer / edited by Francesco Soria, Paolo Gontero.
其他作者:	Soria, Francesco.
面頁冊數:	VIII, 133 p. 25 illus., 18 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Urology. -
電子資源:	https://doi.org/10.1007/978-3-319-78559-2
ISBN:	9783319785592

Treating Urothelial Bladder Cancer
Treating Urothelial Bladder Cancer [electronic resource] /edited by Francesco Soria, Paolo Gontero. - 1st ed. 2018. - VIII, 133 p. 25 illus., 18 illus. in color.online resource.

Preface -- Part I: Bladder cancer diagnosis -- Imaging and bladder cancer: can we do better? -- Optical improvements in bladder cancer diagnosis: seeing better for a better management -- Enhancing the quality of transurethral resection: the importance of a complete TURB and the en-bloc resection -- Active surveillance for low risk non-muscle invasive bladder cancer -- Part II: Non-muscle invasive bladder cancer -- How good we are to predict the outcomes of non-muscle invasive bladder cancer? -- Adjuvant treatment: old and new immunotherapy in non-muscle invasive bladder cancer -- The role of new experimental conservative therapies for high risk non-muscle invasive bladder cancer. Could we trust them? -- Part III: Muscle invasive bladder cancer -- Is there still a role for radical cystectomy? -- Minimally invasive radical cystectomy and its role in the treatment of bladder cancer patients. Myth or reality? -- Neoadjuvant vs adjuvant chemotherapy: which is right? -- Radiotherapy for the treatment of muscle invasive bladder cancer -- Immunotherapy and new combinations -- Part IV: A view on the future -- The role of urologist -- The role of pathologist -- The role of medical oncologist -- The role of radiotherapist.

This book aims to bring together the current research and discussions surrounding bladder cancer management. New technologies and therapeutic agents have become increasingly effective at treating urothelial bladder cancer and have created a range of opportunities to change the ways in which the disease is treated. Chapters cover the changes in adjuvant treatment, confocal laser endomicroscopy, and the roles of oncologists, pathologists, and radiotherapists in managing bladder cancer. Treating Urothelial Bladder Cancer is particularly relevant to urologists, oncologists, and radiotherapists, but is also applicable to practitioners, geriatricians, and public health managers due to its multidisciplinary approach to bladder cancer management.

ISBN: 9783319785592

Standard No.: 10.1007/978-3-319-78559-2doiSubjects--Topical Terms:

645258
Urology.

LC Class. No.: RC870-923.2

Dewey Class. No.: 616.6

Treating Urothelial Bladder Cancer
LDR:03341nam a22004095i 4500 001 987803
003 DE-He213
005 20200629125844.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319785592 $9 978-3-319-78559-2
024 7 $a 10.1007/978-3-319-78559-2 $2 doi
035 $a 978-3-319-78559-2
050 4 $a RC870-923.2
050 4 $a RC875-899.5
072 7 $a MJS $2 bicssc
072 7 $a MED088000 $2 bisacsh
072 7 $a MJS $2 thema
082 0 4 $a 616.6 $2 23
245 1 0 $a Treating Urothelial Bladder Cancer $h [electronic resource] / $c edited by Francesco Soria, Paolo Gontero.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a VIII, 133 p. 25 illus., 18 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Preface -- Part I: Bladder cancer diagnosis -- Imaging and bladder cancer: can we do better? -- Optical improvements in bladder cancer diagnosis: seeing better for a better management -- Enhancing the quality of transurethral resection: the importance of a complete TURB and the en-bloc resection -- Active surveillance for low risk non-muscle invasive bladder cancer -- Part II: Non-muscle invasive bladder cancer -- How good we are to predict the outcomes of non-muscle invasive bladder cancer? -- Adjuvant treatment: old and new immunotherapy in non-muscle invasive bladder cancer -- The role of new experimental conservative therapies for high risk non-muscle invasive bladder cancer. Could we trust them? -- Part III: Muscle invasive bladder cancer -- Is there still a role for radical cystectomy? -- Minimally invasive radical cystectomy and its role in the treatment of bladder cancer patients. Myth or reality? -- Neoadjuvant vs adjuvant chemotherapy: which is right? -- Radiotherapy for the treatment of muscle invasive bladder cancer -- Immunotherapy and new combinations -- Part IV: A view on the future -- The role of urologist -- The role of pathologist -- The role of medical oncologist -- The role of radiotherapist.
520 $a This book aims to bring together the current research and discussions surrounding bladder cancer management. New technologies and therapeutic agents have become increasingly effective at treating urothelial bladder cancer and have created a range of opportunities to change the ways in which the disease is treated. Chapters cover the changes in adjuvant treatment, confocal laser endomicroscopy, and the roles of oncologists, pathologists, and radiotherapists in managing bladder cancer. Treating Urothelial Bladder Cancer is particularly relevant to urologists, oncologists, and radiotherapists, but is also applicable to practitioners, geriatricians, and public health managers due to its multidisciplinary approach to bladder cancer management.
650 0 $a Urology. $3 645258
650 0 $a Oncology . $3 1253469
650 0 $a Radiotherapy. $3 593952
650 2 4 $a Oncology. $3 593951
700 1 $a Soria, Francesco. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1207768
700 1 $a Gontero, Paolo. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1075483
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319785585
776 0 8 $i Printed edition: $z 9783319785608
776 0 8 $i Printed edition: $z 9783030087302
856 4 0 $u https://doi.org/10.1007/978-3-319-78559-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)